Marxaladda 3A Kansarka Sambabka Unugyada yar-yar

Qeexitaanka, Calaamadaha, Daaweynta, iyo Saadaasha Heerka IIIA Kansarka Sambabka

Heerka 3A ee kansarka sambabada unugyada yaryar waxaa loo tixgeliyaa "kansar heer sare ah", taas oo macnaheedu yahay in burada aan ku faafin gobollada fog ee jirka laakiin uu ku faafay qanjidhada nudaha ku yaala dhinaca kale ee jirka sida buro. Qiyaastii boqolkiiba 10 dadku waxay qabaan kansarka sanbabada 3A waqtiga cudurka, iyada oo boqolkiiba 60 dadka qaba marxalado hor leh oo cudurka ah.

Guudmarka

Marxaladda kaansarka sanbabka 3A waxaa ka mid ah buro weyn oo ku faafay qulqulka qanjidhada u dhow, ama burooyin qiyaas kasta oo ku faafay qanjirada noodhka oo ka sii fogaaday, laakiin weli dhinaca jirka ee kansarka.

Dhakhtarrada Onkologists waxay isticmaalaan nidaamka TNM si loo sii qeexo marxaladaha kansarka sanbabada. Sharax fudud oo nidaamka TNM ah waxaa ka mid ah:

T - Taas macnaheedu wuxuu yahay cabbirka burooyinka:

N waxa loola jeedaa qanjidhada qanjidhada:

M wuxuu u taagan yahay cudurkeenaha :

Isticmaalka Nidaamka TNM, Kansarka Sambabka 3A waxaa lagu tilmaamay:

Astaamaha

Calaamadaha marxaladda 3A ee kansarka sanbabadu waa isbeddel taniyo marxaladda 3A waxaa ka mid ah noocyo badan oo kansar ah. Astaamaha waxaa keena kansarka sanbabada sida qufac joogto ah , neefta oo gaabisa , iyo infekshannada soo noqnoqda sida pneumonia ama boronkiitada waa caadi. Ku faafidda meelaha sida xuubka laabta iyo diaphragm waxay sababi kartaa xanuunka laabta, feeraha, garbaha, iyo gadaal. Dhuumaha ku yaal meel u dhow hawo-mareenada ayaa sababi kara dhiigkarka ( qufaca dhiiga ), xiiq , iyo xabeeb .

Daaweynta

Daaweynta marxaladda 3A ee kansarka ayaa ah kuwa ugu murugsan dhammaan heerarka kansarka sanbabada, qayb ahaan sababtoo ah kooxdani way kala duwan tahay. Sababtoo ah heerka nafaqada ee saboolka ah, Machadka Qaranka ee Kansarka ayaa sheegay in qof kasta oo qaba cudurka kansarka sanbabada 3A waa in loo tixgeliyaa musharax tijaabo ah - baadhitaano qiimeynaya daaweyn cusub ama isku-darka daaweynta kansarka sanbabada.

Xaaladaha qaarkood, qalliin ayaa loo samayn karaa si looga saaro burooyinka, waxaana badanaa lala socdaa daweynta kiimikada ee daaweynta (kemotherabi ka dib qaliinka). Chemotherapy (chemotherapy ka hor qaliinka) ayaa lagu ogaadey inuu sii wanaajinayo badbaadada daraasado yar. Chemotherapy isku-dar ah (iyadoo la adeegsanayo daawooyinka kemotherabi) oo ay weheliso daaweynta shucaaca ama daaweyn kale ayaa badanaa la isticmaalaa haddii marxaladda 3A-da ee kansarka sanbabada loo arko mid aan la shaqayn karin sababtoo ah meeshii uu ku faafay, ama haddii caafimaadkaaga guud uu qatar galin lahaa. Kuwa aan awoodin inay u dulqaataan qalliin ama kiimoteraabiya, daaweynta shucaaca ayaa ah ikhtiyaar.

Waxaa muhiim ah in qof kasta qaba kansarka sanbabada unugyada yaryar, gaar ahaan sanbabada adenokarcinoma uu leeyahay baaritaanka hidda-socodka (sheyga molecular) . Waxaa jira dhowr isbedel oo "la daweyn karo" sida isbeddellada EGFR , dib-u-habaynta ALK , iyo ROS1 dib-u-hagaajin kuwaas oo u rogay kansarrada qanjidhada qaarkood oo ku dhowa cudur daran.

Immunotherapy sidoo kale waa doorasho xiiso leh dadka qaarkood , iyada oo wakiilka ugu horreeya ee kooxdan lagu aqoonsaday daaweynta kansarka sanbabada sanadka 2015, waxaa jira afar daawo oo la heli karo. Inkasta oo daaweynadani aysan u shaqeynin qof walba, dadka qaarkood waxay haysteen xakameyn muddo dheer ah oo ay ku hayaan dawooyinkooda. Infinzi (durvalumab) ayaa la ansixiyey sannadkii 2018 gaar ahaan daaweynta marxaladda 3 kaansarka unugyada yar-yar ee unugyada yar-yar ee aan shaqaynayn. Marka la isticmaalo daaweynta kiimikada iyo shucaaca, waxaa la ogaaday in lagu wanaajinayo badbaadada aan sii wanagsaneyn.

Saadaasha

Qiyaasta guud ee badbaadada 5-sanno ee heerka kansarka sanbabada 3A waa 14%, laakiin tani way is badashaa kansarrada kala duwan ee loo yaqaan heerka stage 3A. Maskaxda ku hay in tirakoobyada ay noo sheegaan sida dadku u sameeyeen sannado badan, iyo horumarin badan ayaa ka dhacay daweynta kansarka sanbabada dhawrkii sano ee la soo dhaafay. Waxaa jira meel aad u badan oo lagu rajeynayo daaweynta kansarka sanbabada taas oo ah tan hore.

Taageero

Cilmi-baaristu waxay soo jeedinaysaa in aad baran karto waxa aad ka qaban karto kansarkaaga ku caawinaayo natiijada. Dhammaan marxaladaha kansarka sanbabada, marxaladda 3A waa kuwa ugu badan oo ay ku jiraan tirada ugu badan ee fursadaha daaweynta. Weydii su'aalo. Ka qayb gali kuwa aad jeceshahay kuna dhiiri geli inay su'aalo weydiiyaan. Ka fikir inaad ku biirto koox taageero ah . Baro tijaabooyinka caafimaad ee laga yaabo in ay ku haboon tahay xaaladdaada gaarka ah. Barashada kansarkaaga iyo daaweyntaada daaweynta waxay qaadan kartaa waqti aad u ballaaran. Weydii, una ogolow dadka aad jeceshahay iyo saaxiibbada inay ku caawiyaan kuna dhiiri geliyaan safarkaaga. Qaado daqiiqad si aad u hubiso talooyinkan ku saabsan sida loo noqdo u-doodahaada ku jira daryeelkaaga kansarka . Halkaan waxaa ku qoran talooyin ku saabsan siyaabaha lagu wanaajinayo badbaadada kansarka sanbabada oo uusan dhakhtarkaagu sheegin.

Markaad Hayso Qof Kacbada Leh Kansarkaaga

Haddii ay tahay qofka aad jeceshahay oo laga helay kansarka sanbabada, waxaad u maleyneysaa inaad si isku mid ah u cabsi badan tahay, iyo noqoshada daryeel-bixiye qoys ee qof qaba cudurkani wuxuu kaa tagi karaa inaad dareentid jahwareer iyo qalbi la'aan. Qaado daqiiqad iyo hubi maqaalkan oo cinwaankeedu yahay " markaad jeceshahay kansarka sanbabada " si aad u maqasho dadka qaba kansarka sanbabku waxay rajeynayaan in ay jecelyihiin. Halkan waxaa ku qoran qaar ka mid ah talooyin iyo sidoo kale taageerida qof jecel kansarka .

Ilaha:

Society Cancer Society. Xaqiiqooyinka Kansarka iyo Sawirrada 2014 . Atlanta: Bulshada Mareykanka ee Kansarka; 2014. http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf

Society Cancer Society. Kansarka Sambabka (Unugyada Hoose-yar). Qiyaasaha Kansarka Cudurka Kansarka Cudurka aan-yareyn ee Qaybaha Heerka. 02/08/16. http://www.cancer.org/cancer/lungcancer-non-smallcell/detailedguide/non-small-cell-lung-cancer-survival-rates

Guddiga Wadajirka ee Maraykanka ee Kansarka. Kansarka Lung Cancer. Warka 7aad. Gaaray 09/20/14. https://cancerstaging.org/references-tools/quickreferences/Documents/LungMedium.pdf

> Antonia, S., Villegas, A., Daniel, D. et al. Durvalumab Ka Dib Daaweynta Chemoradioterapia ee Heerka III Kansarka Qanjada Sambabka ee aan-yareyn. Wargeyska New England Journal of Medicine . 2017. 377: 1919-1929.

Edge, S. et al (Eds.). Buugga Dheecaanka Kansarka AJCC. Warka 7aad. Duufaan. New York, NY. 2010.

Machadka Kansarka Qaranka. Daaweynta kaansarka sanbabada aan-yareyn (PDQ) http://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq#section/all

Santos, E. et al. Dhibaatooyinka ku jira maareynta marxaladda IIIA-da ee unugyada yar-yar ee unugyada sambabada. Dib-u-eegis Khabiir ah ee Daaweynta La-talinta . 2008. 8 (12): 1913-29.